Legal status · Canada
Is Rilmenidine legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Rilmenidine is not an approved medicine in Canada; its classification is "Availability varies by market". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Rilmenidine in Canada at a glance
| Classification | Availability varies by market |
|---|---|
| Note | We could not confirm a current Canadian authorisation as of September 2026. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 1 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Rilmenidine profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Rilmenidine is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Rilmenidine is
A European blood pressure drug that extends lifespan in Caenorhabditis elegans through the nischarin receptor. In mammals the record is worse than neutral: it induced autophagy as designed in two mouse models of motor neuron disease and made both of them worse.
Rilmenidine is a centrally acting antihypertensive that works through the I1-imidazoline receptor. It entered geroscience sideways, through a screen for compounds whose gene expression signature resembles caloric restriction, and it came out near the top.
Mechanism: Agonist at the I1-imidazoline receptor, with weaker alpha-2 adrenoceptor activity than clonidine, which is why it lowers blood pressure with less sedation. The geroscience mechanism proposed is induction of mTOR-independent autophagy plus a transcriptional state resembling caloric restriction.
Regulatory history: Not approved in the United States. Rilmenidine is a Servier product licensed as an antihypertensive in France and several other European markets under the names Hyperium, Tenaxum, Albarel and Iterium.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Rilmenidine at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Rilmenidine in other countries
Frequently asked questions
Is Rilmenidine legal in Canada?
No. Rilmenidine is not an approved medicine in Canada; its classification is "Availability varies by market". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: We could not confirm a current Canadian authorisation as of September 2026.
Can I buy Rilmenidine in Canada?
No approved product exists to buy. In Canada Rilmenidine is classified as "Availability varies by market", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: We could not confirm a current Canadian authorisation as of September 2026.
Is Rilmenidine Health Canada approved?
No. In Canada Rilmenidine is classified as "Availability varies by market", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved in the United States. Rilmenidine is a Servier product licensed as an antihypertensive in France and several other European markets under the names Hyperium, Tenaxum, Albarel and Iterium.. On the evidence, 1 human study is cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Rilmenidine live on its compound profile.
Rilmenidine profileThis page is general information about the regulatory status of Rilmenidine in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.